Who invested in Chondrial Therapeutics?
Chondrial Therapeutics's investors include LD Capital and Deerfield.
United States · Series B startup
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$27Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Mar 2014
From the SEC filings it signed: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Chondrial Therapeutics's investors include LD Capital and Deerfield.
Chondrial Therapeutics has raised $27M across 2 rounds since 2014.
Chondrial Therapeutics's most recent round was a Series B of $26M in May 2019.
Its most recent round, $26M in May 2019, is also its largest on record.
Chondrial Therapeutics's first round on record, in May 2019, was backed by LD Capital and Deerfield.
Chondrial Therapeutics's latest named round is a Series B, in May 2019.
Chondrial Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.